Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The New Protocols and Standards of One of Florida's Leading Testosterone Therapy Programs -- Testosterone149
  • USA - English


News provided by

[email protected]

Sep 09, 2013, 07:30 ET

Share this article

Share toX

Share this article

Share toX


Palm Beach, Florida (PRWEB) September 09, 2013 -- Clinics have been popping up everywhere and private-physician practices suddenly take pride in their hormone-therapy expertise.

Be smarter and get the right information!

“Essentially, the younger the man, the more scrutinizing the lab profile workup should be,” says Dr. Berman

Post this

Dr. Berman – a leading physician and founder of the Testosterone149 Program – has been practicing Hormone Replacement Therapy for over 15 years. Originally trained in urology and surgery, Dr. Berman is a true expert when it comes to Hormone Replacement Therapy. His thorough knowledge in this specialty stems from extensive research and fellowship programs, as well as from years of specializing in Hormone Correction.

The Testosterone149 Program was designed for the 'Aging Male,' a term that encompasses men over the age of 40 who experience symptoms of Erectile Dysfunction, Depression, Irritability, Excessive Weight Gain and Sleepless Nights. “These are our patients and are the ideal candidates for our program," explains Dr. Berman. "Not the 32-year-old calling our offices claiming they would like to work out harder and look better at the gym."

“Essentially, the younger the man, the more scrutinizing the lab profile workup should be,” says Dr. Berman, claiming that a healthy 40-year-old should not suffer from low Testosterone. But if that is the case, it may be due to a myriad of conditions such as infectious diseases like the Mumps and STDs; issues with the Pituitary Gland; consuming certain medications; using Testosterone inappropriately; drug or alcohol abuse; or serious underlying diseases. All of these conditions should be reviewed and addressed prior to therapy and only true Testicular Hypofunction should be treated with Testosterone Therapy.

For those that are not aware, Testosterone Therapy is a very serious and complicated process that needs to be carefully monitored and supervised; it can have extreme consequences if fallen into the wrong hands. Men who do not suffer from true testicular Hypofunction, should not take Testosterone in order to avoid future problems. There is a reason why Testosterone is a controlled substance and is not prescribed freely.

Dr. Berman’s clinic and the Testosterone149 Program is valued as one of the best treatment options. They have a strict policy for patient acceptance, meticulous diagnostic approach and a prudent medication injection regime. “It’s not rocket science,” says Dr. Berman. But "patients need to follow our strict timeline” for best outcomes.

Less is more….

“The fact of the matter Testosterone Therapy is a commitment for the rest of your life; once you start, you won’t want to stop," says Dr. Berman. “My policy is less is more. You will be surprised at how many patients demand and expect ridiculous Testosterone doses. At these doses, very quickly one will develop a condition similar to Diabetes-- when super high levels of Testosterone cause Testosterone resistance in the body and loss of Testosterone effect; increased Estrogen; loss of libido; hair loss; and other unwanted adverse effects."

Testosterone Replacement Therapy is a gradual process that needs to be closely supervised and monitored by a physician. Patients who expect to reach the Testosterone 'High' are simply overdosing themselves on Testosterone, causing their bodies to gradually overload the Testosterone receptors and develop a permanent Testosterone 'Low' requiring prolonged detoxification periods.

The Testosterone149 Program strives to ensure that all patients achieve optimal levels of Testosterone. This is determined by optimizing Free Testosterone and not by blindly increasing the dose, which you could expect from inexperienced Physicians or clinics. In addition, this approach of increased doses prevents abnormal production of the female hormone Estrogen and significant shrinkage of the testicles, which are common side effects of inappropriate Testosterone Therapy.

Many clinics that recently entered the field of Testosterone supplementation are using doses resembling those used for bodybuilding. Therefore, they almost universally encounter unwanted consequences and thus the need to prescribe Estrogen blockers and HCG to offset side effects. Many of them are not aware that over-suppressing estrogen may lead to Osteopenia (Bone Reabsorption) and loss of sex drive, and that HCG is associated with Gynecomastia (Man Boobs).

The goal of the Testosterone149 Program is to achieve Optimal BALANCE of Hormones, not high Testosterone levels.

The most important thing to remember is that when your body experiences a hormonal shortage, it needs just enough of it --not less and not more.

Testosterone149, [email protected], http://www.testosterone149.com, 888-804-1632, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.